{"pmid":32487868,"title":"Cardiac imaging in congenital heart disease during the coronavirus disease-2019 pandemic: recommendations from the Working Group on Congenital Heart Disease of the Italian Society of Cardiology.","text":["Cardiac imaging in congenital heart disease during the coronavirus disease-2019 pandemic: recommendations from the Working Group on Congenital Heart Disease of the Italian Society of Cardiology.",": The recent outbreak of 2019 severe acute respiratory syndrome coronavirus-2 is having major repercussions on healthcare services provision in Italy and worldwide. Data suggest the virus has a strong impact on the cardiovascular system, and cardiac imaging will play an important role in patients affected by coronavirus disease-2019. Although paediatric patients are mildly affected, they represent a clear accelerator in spreading the virus, and healthcare workers are at higher risk of infection. The aim of this position paper is to provide clinical recommendation regarding the execution of imaging investigations for the cardiac diagnostic work-up of paediatric patients with suspected or confirmed infection.","J Cardiovasc Med (Hagerstown)","Sirico, Domenico","Castaldi, Biagio","Ciliberti, Paolo","Sabatino, Jolanda","Cazzoli, Ilaria","Secinaro, Aurelio","Calcaterra, Giuseppe","Oreto, Lilia","Calabro, Maria Pia","Chessa, Massimo","Limongelli, Giuseppe","D'Alto, Michele","Serra, Walter","Bassareo, Pierpaolo","Russo, Maria Giovanna","Guccione, Paolo","Di Salvo, Giovanni","32487868"],"abstract":[": The recent outbreak of 2019 severe acute respiratory syndrome coronavirus-2 is having major repercussions on healthcare services provision in Italy and worldwide. Data suggest the virus has a strong impact on the cardiovascular system, and cardiac imaging will play an important role in patients affected by coronavirus disease-2019. Although paediatric patients are mildly affected, they represent a clear accelerator in spreading the virus, and healthcare workers are at higher risk of infection. The aim of this position paper is to provide clinical recommendation regarding the execution of imaging investigations for the cardiac diagnostic work-up of paediatric patients with suspected or confirmed infection."],"journal":"J Cardiovasc Med (Hagerstown)","authors":["Sirico, Domenico","Castaldi, Biagio","Ciliberti, Paolo","Sabatino, Jolanda","Cazzoli, Ilaria","Secinaro, Aurelio","Calcaterra, Giuseppe","Oreto, Lilia","Calabro, Maria Pia","Chessa, Massimo","Limongelli, Giuseppe","D'Alto, Michele","Serra, Walter","Bassareo, Pierpaolo","Russo, Maria Giovanna","Guccione, Paolo","Di Salvo, Giovanni"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32487868","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.2459/JCM.0000000000000990","locations":["Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1668623433664036864,"score":9.490897,"similar":[{"pmid":32415767,"title":"Valvular and structural heart disease management during the COVID-19 pandemic. Expert opinion of the Working Group on Valvular Heart Diseases, the Working Group on Cardiac Surgery, and the Association of Cardiovascular Interventions of the Polish Cardiac Society.","text":["Valvular and structural heart disease management during the COVID-19 pandemic. Expert opinion of the Working Group on Valvular Heart Diseases, the Working Group on Cardiac Surgery, and the Association of Cardiovascular Interventions of the Polish Cardiac Society.","Ongoing pandemics of SARS-CoV-2 coronavirus disease 2019 (COVID-19) represents a major challenge for healthcare. Beside the proven involvement of cardiovascular system in COVID-19, increased healthcare system resources are redirected towards handling infected patients and thus induce major changes in access to services and priorities in the management of patients with unrelated chronic cardiovascular disease. This document, created by task force involving Working Groups on Valvular Heart Disease and Cardiac Surgery as well as Association of Cardiovascular Intervention, Polish Cardiac Society proposes modifications of diagnostic pathways, principles of healthcare professionals protection and guidelines for treatment according to triage and prioritization. Valvular heart teams should continue working with utilization of telemedicine and digital technology. Diagnostic tests must be simplified or deferred to minimize potentially dangerous aerosol generating procedures such as transesophageal echocardiography or exercise imaging. Treatments for aortic stenosis and mitral regurgitation have to be offered especially in urgent indications and in patients with advanced disease and poor prognosis. Expert risk stratification is essential for triage and setting the priority lists. In any case, appropriate level of personal protection must be ensured for healthcare personnel to prevent spreading infections and preserving specialized manpower to supply for the continuing need of handling chronic serious cardiovascular disease. Importantly, as soon as the local epidemic situation improves, efforts must be made to rebuild standard opportunities for elective treatment of valvular heart disease and occluder-based therapies according to existing guidelines, thus rebuilding stat-of-the-art cardiovascular services.","Kardiol Pol","Plonska-Gosciniak, Edyta","Suwalski, Piotr","Bartus, Stanislaw","Kukulski, Tomasz","Komar, Monika","Wojakowski, Wojciech","Grygier, Marek","Pruszczyk, Piotr","Gasior, Zbigniew","Huczek, Zenon","Berger-Kucza, Adrianna","Bak, Janusz","Sorysz, Danuta","Kasprzak, Jaroslaw D","32415767"],"abstract":["Ongoing pandemics of SARS-CoV-2 coronavirus disease 2019 (COVID-19) represents a major challenge for healthcare. Beside the proven involvement of cardiovascular system in COVID-19, increased healthcare system resources are redirected towards handling infected patients and thus induce major changes in access to services and priorities in the management of patients with unrelated chronic cardiovascular disease. This document, created by task force involving Working Groups on Valvular Heart Disease and Cardiac Surgery as well as Association of Cardiovascular Intervention, Polish Cardiac Society proposes modifications of diagnostic pathways, principles of healthcare professionals protection and guidelines for treatment according to triage and prioritization. Valvular heart teams should continue working with utilization of telemedicine and digital technology. Diagnostic tests must be simplified or deferred to minimize potentially dangerous aerosol generating procedures such as transesophageal echocardiography or exercise imaging. Treatments for aortic stenosis and mitral regurgitation have to be offered especially in urgent indications and in patients with advanced disease and poor prognosis. Expert risk stratification is essential for triage and setting the priority lists. In any case, appropriate level of personal protection must be ensured for healthcare personnel to prevent spreading infections and preserving specialized manpower to supply for the continuing need of handling chronic serious cardiovascular disease. Importantly, as soon as the local epidemic situation improves, efforts must be made to rebuild standard opportunities for elective treatment of valvular heart disease and occluder-based therapies according to existing guidelines, thus rebuilding stat-of-the-art cardiovascular services."],"journal":"Kardiol Pol","authors":["Plonska-Gosciniak, Edyta","Suwalski, Piotr","Bartus, Stanislaw","Kukulski, Tomasz","Komar, Monika","Wojakowski, Wojciech","Grygier, Marek","Pruszczyk, Piotr","Gasior, Zbigniew","Huczek, Zenon","Berger-Kucza, Adrianna","Bak, Janusz","Sorysz, Danuta","Kasprzak, Jaroslaw D"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32415767","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.33963/KP.15358","locations":["Polish"],"countries":["Poland"],"countries_codes":["POL|Poland"],"topics":["Prevention"],"weight":1,"_version_":1666994545911398400,"score":213.4618},{"pmid":32441586,"title":"Coronavirus Disease 2019 (COVID-19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease.","text":["Coronavirus Disease 2019 (COVID-19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease.","The corona virus disease -2019 (COVID-19) is a recently described infectious disease caused by the severe acute respiratory syndrome corona virus 2 with significant cardiovascular implications. Given the increased risk for severe COVID-19 observed in adults with underlying cardiac involvement, there is concern that patients with pediatric and congenital heart disease (CHD) may likewise be at increased risk for severe infection. The cardiac manifestations of COVID-19 include myocarditis, arrhythmia and myocardial infarction. Importantly, the pandemic has stretched health care systems and many care team members are at risk for contracting and possibly transmitting the disease which may further impact the care of patients with cardiovascular disease. In this review, we describe the effects of COVID-19 in the pediatric and young adult population and review the cardiovascular involvement in COVID-19 focusing on implications for patients with congenital heart disease in particular.","J Am Heart Assoc","Alsaied, Tarek","Aboulhosn, Jamil A","Cotts, Timothy B","Daniels, Curt J","Etheridge, Susan P","Feltes, Timothy F","Gurvitz, Michelle Z","Lewin, Mark B","Oster, Matthew E","Saidi, Arwa","32441586"],"abstract":["The corona virus disease -2019 (COVID-19) is a recently described infectious disease caused by the severe acute respiratory syndrome corona virus 2 with significant cardiovascular implications. Given the increased risk for severe COVID-19 observed in adults with underlying cardiac involvement, there is concern that patients with pediatric and congenital heart disease (CHD) may likewise be at increased risk for severe infection. The cardiac manifestations of COVID-19 include myocarditis, arrhythmia and myocardial infarction. Importantly, the pandemic has stretched health care systems and many care team members are at risk for contracting and possibly transmitting the disease which may further impact the care of patients with cardiovascular disease. In this review, we describe the effects of COVID-19 in the pediatric and young adult population and review the cardiovascular involvement in COVID-19 focusing on implications for patients with congenital heart disease in particular."],"journal":"J Am Heart Assoc","authors":["Alsaied, Tarek","Aboulhosn, Jamil A","Cotts, Timothy B","Daniels, Curt J","Etheridge, Susan P","Feltes, Timothy F","Gurvitz, Michelle Z","Lewin, Mark B","Oster, Matthew E","Saidi, Arwa"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32441586","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1161/JAHA.120.017224","keywords":["covid-19","adult congenital heart disease","congenital heart disease","pediatric cardiology"],"topics":["Prevention"],"weight":1,"_version_":1667535119524560896,"score":186.08353},{"pmid":32248966,"pmcid":"PMC7102656","title":"The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease.","text":["The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease.","Coronavirus disease 2019 (COVID-19), caused by a novel betacoronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first described in a cluster of patients presenting with pneumonia symptoms in Wuhan, China, in December of 2019. Over the past few months, COVID-19 has developed into a worldwide pandemic, with over 400,000 documented cases globally as of March 24, 2020. The SARS-CoV-2 virus is most likely of zoonotic origin, but has been shown to have effective human-to-human transmission. COVID-19 results in mild symptoms in the majority of infected patients, but can cause severe lung injury, cardiac injury, and death. Given the novel nature of COVID-19, no established treatment beyond supportive care exists currently, but extensive public-health measures to reduce person-to-person transmission of COVID-19 have been implemented globally to curb the spread of disease, reduce the burden on healthcare systems, and protect vulnerable populations, including the elderly and those with underlying medical comorbidities. Since this is an emerging infectious disease, there is, as of yet, limited data on the effects of this infection on patients with cardiovascular disease, particularly so for those with congenital heart disease. We summarize herewith the early experience with COVID-19 and consider the potential applicability to and implications for patients with cardiovascular disease in general and congenital heart disease in particular.","Int J Cardiol","Tan, Weiyi","Aboulhosn, Jamil","32248966"],"abstract":["Coronavirus disease 2019 (COVID-19), caused by a novel betacoronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first described in a cluster of patients presenting with pneumonia symptoms in Wuhan, China, in December of 2019. Over the past few months, COVID-19 has developed into a worldwide pandemic, with over 400,000 documented cases globally as of March 24, 2020. The SARS-CoV-2 virus is most likely of zoonotic origin, but has been shown to have effective human-to-human transmission. COVID-19 results in mild symptoms in the majority of infected patients, but can cause severe lung injury, cardiac injury, and death. Given the novel nature of COVID-19, no established treatment beyond supportive care exists currently, but extensive public-health measures to reduce person-to-person transmission of COVID-19 have been implemented globally to curb the spread of disease, reduce the burden on healthcare systems, and protect vulnerable populations, including the elderly and those with underlying medical comorbidities. Since this is an emerging infectious disease, there is, as of yet, limited data on the effects of this infection on patients with cardiovascular disease, particularly so for those with congenital heart disease. We summarize herewith the early experience with COVID-19 and consider the potential applicability to and implications for patients with cardiovascular disease in general and congenital heart disease in particular."],"journal":"Int J Cardiol","authors":["Tan, Weiyi","Aboulhosn, Jamil"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32248966","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.ijcard.2020.03.063","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Mechanism","Prevention","Treatment"],"weight":1,"_version_":1666138490935443457,"score":180.79778},{"pmid":32451877,"pmcid":"PMC7247913","title":"Cardiac imaging procedures and the COVID-19 pandemic: recommendations of the European Society of Cardiovascular Radiology (ESCR).","text":["Cardiac imaging procedures and the COVID-19 pandemic: recommendations of the European Society of Cardiovascular Radiology (ESCR).","The severe acute respiratory syndrome coronavirus 2019 (SARS-CoV-2) pandemic currently constitutes a significant burden on worldwide health care systems, with important implications on many levels, including radiology departments. Given the established fundamental role of cardiovascular imaging in modern healthcare, and the specific value of cardiopulmonary radiology in COVID-19 patients, departmental organisation and imaging programs need to be restructured during the pandemic in order to provide access to modern cardiovascular services to both infected and non-infected patients while ensuring safety for healthcare professionals. The uninterrupted availability of cardiovascular radiology services remains, particularly during the current pandemic outbreak, crucial for the initial evaluation and further follow-up of patients with suspected or known cardiovascular diseases in order to avoid unnecessary complications. Suspected or established COVID-19 patients may also have concomitant cardiovascular symptoms and require further imaging investigations. This statement by the European Society of Cardiovascular Radiology (ESCR) provides information on measures for safety of healthcare professionals and recommendations for cardiovascular imaging during the pandemic in both non-infected and COVID-19 patients.","Int J Cardiovasc Imaging","Beitzke, Dietrich","Salgado, Rodrigo","Francone, Marco","Kreitner, Karl-Friedrich","Natale, Luigi","Bremerich, Jens","Gutberlet, Matthias","Mousseaux, Ellie","Nikolaou, Konstantin","Peebles, Charles","Velthuis, Birgitta","Vliegenthart, Rozemarijn","Loewe, Christian","Emrich, Tilman","Luigi, Natale","Matthias, Gutberlet","Rozemarijn, Vliegenthart","Konstantin, Nikolaou","Marco, Francone","Christian, Loewe","Brigitta, Velthuis","Rodrigo, Salgado","Charles, Peebles","Ellie, Mousseaux","32451877"],"abstract":["The severe acute respiratory syndrome coronavirus 2019 (SARS-CoV-2) pandemic currently constitutes a significant burden on worldwide health care systems, with important implications on many levels, including radiology departments. Given the established fundamental role of cardiovascular imaging in modern healthcare, and the specific value of cardiopulmonary radiology in COVID-19 patients, departmental organisation and imaging programs need to be restructured during the pandemic in order to provide access to modern cardiovascular services to both infected and non-infected patients while ensuring safety for healthcare professionals. The uninterrupted availability of cardiovascular radiology services remains, particularly during the current pandemic outbreak, crucial for the initial evaluation and further follow-up of patients with suspected or known cardiovascular diseases in order to avoid unnecessary complications. Suspected or established COVID-19 patients may also have concomitant cardiovascular symptoms and require further imaging investigations. This statement by the European Society of Cardiovascular Radiology (ESCR) provides information on measures for safety of healthcare professionals and recommendations for cardiovascular imaging during the pandemic in both non-infected and COVID-19 patients."],"journal":"Int J Cardiovasc Imaging","authors":["Beitzke, Dietrich","Salgado, Rodrigo","Francone, Marco","Kreitner, Karl-Friedrich","Natale, Luigi","Bremerich, Jens","Gutberlet, Matthias","Mousseaux, Ellie","Nikolaou, Konstantin","Peebles, Charles","Velthuis, Birgitta","Vliegenthart, Rozemarijn","Loewe, Christian","Emrich, Tilman","Luigi, Natale","Matthias, Gutberlet","Rozemarijn, Vliegenthart","Konstantin, Nikolaou","Marco, Francone","Christian, Loewe","Brigitta, Velthuis","Rodrigo, Salgado","Charles, Peebles","Ellie, Mousseaux"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32451877","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1007/s10554-020-01892-8","keywords":["covid-19","cardiac magnetic resonance","cardiovascular computed tomography","sars-cov-2","safety"],"topics":["Prevention"],"weight":1,"_version_":1667983494498746369,"score":178.85002},{"pmid":32474800,"title":"Children's heart and COVID-19: Up-to-date evidence in the form of a systematic review.","text":["Children's heart and COVID-19: Up-to-date evidence in the form of a systematic review.","The new coronavirus disease outbreak in 2019 (COVID-19) represents a dramatic challenge for healthcare systems worldwide. As to viral tropism, lungs are not the only COVID-19 target but also the heart may be involved in a not negligible percentage of the infected patients. Myocarditis-related cardiac dysfunction and potentially life-threatening arrhythmias are the main aftermaths. A few studies showed that myocardial injury in adult patients is often linked with a fatal outcome. Conversely, scientific evidence in children is sparse, although several reports were published with the description of a cardiac involvement in COVID-19 paediatric patients. In these young subjects, a background of surgically treated congenital heart disease seems to be a predisposing factor.Conclusion: This systematic review is aimed at summarizing all COVID-19 cases with a cardiac involvement published in paediatric age and trying to explain the underlying mechanisms responsible for COVID-19-related myocardial damage.What is Known:* Coronaviruses proved to be able to jump from animals to humans.* The outbreak of COVID-19 started from China (Dec 2019) and became pandemic.What is New:* Even in childhood, COVID-19 is not without the risk of cardiac involvement.* Myocarditis, heart failure, and arrhythmias are among the possible manifestations.","Eur J Pediatr","Sanna, Giulia","Serrau, Gaia","Bassareo, Pier Paolo","Neroni, Paola","Fanos, Vassilios","Marcialis, Maria Antonietta","32474800"],"abstract":["The new coronavirus disease outbreak in 2019 (COVID-19) represents a dramatic challenge for healthcare systems worldwide. As to viral tropism, lungs are not the only COVID-19 target but also the heart may be involved in a not negligible percentage of the infected patients. Myocarditis-related cardiac dysfunction and potentially life-threatening arrhythmias are the main aftermaths. A few studies showed that myocardial injury in adult patients is often linked with a fatal outcome. Conversely, scientific evidence in children is sparse, although several reports were published with the description of a cardiac involvement in COVID-19 paediatric patients. In these young subjects, a background of surgically treated congenital heart disease seems to be a predisposing factor.Conclusion: This systematic review is aimed at summarizing all COVID-19 cases with a cardiac involvement published in paediatric age and trying to explain the underlying mechanisms responsible for COVID-19-related myocardial damage.What is Known:* Coronaviruses proved to be able to jump from animals to humans.* The outbreak of COVID-19 started from China (Dec 2019) and became pandemic.What is New:* Even in childhood, COVID-19 is not without the risk of cardiac involvement.* Myocarditis, heart failure, and arrhythmias are among the possible manifestations."],"journal":"Eur J Pediatr","authors":["Sanna, Giulia","Serrau, Gaia","Bassareo, Pier Paolo","Neroni, Paola","Fanos, Vassilios","Marcialis, Maria Antonietta"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32474800","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1007/s00431-020-03699-0","keywords":["covid-19","cardiovascular","coronavirus","heart","myocarditis","severe respiratory distress syndrome"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1668341932705710080,"score":165.73297}]}